Resultados da busca - G. SAYDAM

HEPATITIS B VIRUS PREVALANCE IN TURKIYE YUKSEK IHTISAS HOSPITAL PERSONNEL por Ülkü SARITAŞ, N. KANTAROĞLU, Bülent YILDIRIM, G. SAYDAM, Uğur YILMAZ

Obter o texto integral

HEPATITIS C VIRUS ANTIBODY PREVALANGE IN TURKIYE YUKSEK lHTlSAS HOSPITAL PERSONNEL por Ülkü SARITAŞ, B. YILDIRIM, N. KANTAROGLU, U. YILMAZ, E. ALTIPARMAK, G. SAYDAM, L. ONARAN

Obter o texto integral

Real experience of brentuximab vedotin for cutaneous T cell lymphomas por F. Keklik Karadag, A. Arslan, T. Pashayev, N. Akad Soyer, F. Sahin, F. Vural, M. TöBü, G. Saydam

Obter o texto integral

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL por P. L. Zinzani, M. Özcan, K. Sapunarova, W. Jurczak, A. Hamed, K. Bouabdallah, G. Saydam, K. Geissler, Á. Szomor, M. Lazaroiu, A. Salar, A. Tempescul, M. Nalcaci, L. Gercheva, M. Egyed, P. Panayiotidis, L. Mongay Soler, A. Cao, C. Phelps, B. H Childs, M. J Matasar

Obter o texto integral

B10 | EFFICACY AND SAFETY OF ORAL BRUTON TYROSINE KINASE INHIBITOR RILZABRUTINIB IN ADULTS WITH PREVIOUSLY TREATED IMMUNE THROMBOCYTOPENIA: A PHASE 3, PLACEBO-CONTROLLED, PARALLEL-... por E. Lucchini, D. J. Kuter, W. Ghanima, N. Cooper, H.A. Liebman, L. Zhang, Y. Hu, Y. Miyakawa, L. Galindo, A. Basquiera, C. Tan, G. Saydam, M. Krönke, C. Adisaksopha, D. Almaguer, H. Tran, H. Shin, M. Izquierdo, I. Kirgner, G. Kuzmina, S. Audia, M. Cordoba, R. Diab, M. Yao, M. Lee, A. Daak

Obter o texto integral